NEOPLASMS, GLANDULAR AND EPITHELIAL
Clinical trials for NEOPLASMS, GLANDULAR AND EPITHELIAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, GLANDULAR AND EPITHELIAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, GLANDULAR AND EPITHELIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus therapy takes on childhood brain cancer in early trial
Disease control Recruiting nowThis early-phase study tests whether a specially engineered virus called G207 is safe for children whose cerebellar brain tumors have come back or not responded to standard treatments. Up to 24 children aged 3 to 21 will receive the virus directly into the tumor, along with a low…
Matched conditions: NEOPLASMS, GLANDULAR AND EPITHELIAL
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New combo attack shows promise against tough liver tumors
Disease control Recruiting nowThis study tests a powerful mix of treatments—tumor destruction (ablation), chemotherapy beads (TACE), an immunotherapy drug (tislelizumab), and a targeted therapy (lenvatinib)—for people with liver cancer that cannot be removed by surgery. About 17 adults with advanced liver can…
Matched conditions: NEOPLASMS, GLANDULAR AND EPITHELIAL
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 03, 2026 12:04 UTC